1. Barlow-Mosha, L., Musoke, P., Ajuna, P., Luttajumwa, M., Walabyeki, J., Owor, M., Mubiru M., 2005. Early effectiveness of Triomune in HIV-infected Ugandan children. In: Third International AIDS Society Conference on HIV Pathogenesis and Treatment; 24–27 July 2005; Rio de Janeiro, Brazil [abstract WeOa0103].
2. Antiretroviral treatment in pediatric HIV infection in the United States. From clinical trials to clinical practice;Brogly;JAMA,2005
3. Chimzizi, R., Harries, A., Gausi, F., Salaniponi, F., Libamba, E., Schouten, E., Aberle-Grasse, J., Killam, P., Hochgesang, M., 2005. Report of a country-wide survey of HIV/AIDS services in Malawi for the year 2004. Ministry of Health, Lilongwe, Malawi.
4. Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine;Chokephaibulkit;AIDS,2005
5. Corbett, A., Hosseinipour, M., Nyirenda, J., Kanjama, C., Mshali, I., Chinjama, S., Lyke, A., Rezk, N., Tien, H., Hoffman, I., Kashuba, A., Mwansambo, C., Weigel, R., Kazembe, P., 2005. Pharmacokinetics between trade and generic liquid and split tablet formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children. In: 45th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 16–19 December 2005; Washington, DC [poster 1106].